Chemotherapy assay guidance published, refuted

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1454, 2004-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

DM programme evaluation guidance published in the US

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 435, 2003-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

HBOC meta-analysis refuted by Biopure

Reactions Weekly, Vol. 1, Iss. 1207, 2008-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Research Highlights: Highlights from the most important papers in pharmacogenomics and cancer chemotherapy published in 2013

By Sugino Shigekazu Janicki Piotr K

Pharmacogenomics, Vol. 14, Iss. 16, 2013-12 ,pp. : 1949-1951

Future Medicine

Access to resources Recommend Favorite

ARBs and MI risk refuted in meta-analysis

Reactions Weekly, Vol. 1, Iss. 1350, 2011-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Published Only

Journal of Digestive Diseases, Vol. 16, Iss. S1, 2015-09 ,pp. : 29-146

John Wiley & Sons Inc

Access to resources Recommend Favorite